These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23681102)

  • 1. Implantable cardioverter-defibrillators in patients with COPD.
    Naksuk N; Kunisaki KM; Benditt DG; Tholakanahalli V; Adabag S
    Chest; 2013 Sep; 144(3):778-783. PubMed ID: 23681102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of implantable cardioverter defibrillator shocks during the first year.
    Dougherty CM; Hunziker J
    J Cardiovasc Nurs; 2009; 24(1):21-8; quiz 29-30. PubMed ID: 19114797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated electrocardiographic quantification of myocardial scar in patients undergoing primary prevention implantable cardioverter-defibrillator implantation: Association with mortality and subsequent appropriate and inappropriate therapies.
    Reichlin T; Asatryan B; Vos MA; Willems R; Huikuri HV; Junttila MJ; Schlögl SC; Hnatkova K; Schaer BA; Malik M; Zabel M; Sticherling C;
    Heart Rhythm; 2020 Oct; 17(10):1664-1671. PubMed ID: 32428669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial.
    Aoukar PS; Poole JE; Johnson GW; Anderson J; Hellkamp AS; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2013 Jul; 10(7):970-6. PubMed ID: 23562699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
    Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
    Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between total shock energy and mortality in patients with implantable cardioverter-defibrillator.
    Tenma T; Yokoshiki H; Mitsuyama H; Watanabe M; Mizukami K; Kamada R; Takahashi M; Sasaki R; Maeno M; Okamoto K; Chiba Y; Anzai T
    Int J Cardiol; 2018 May; 259():94-99. PubMed ID: 29486995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure.
    Nomoto M; Suzuki A; Shiga T; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2022 Aug; 22(1):374. PubMed ID: 35974317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
    Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
    Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators.
    Ayan M; Habash F; Alqam B; Gheith Z; Cross M; Vallurupalli S; Paydak H
    Clin Cardiol; 2019 Feb; 42(2):299-304. PubMed ID: 30592068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between ICD interventions and mortality is independent of their modality: clinical implications.
    Bencardino G; Di Monaco A; Rio T; Frontera A; Santangeli P; Leo M; Pelargonio G; Perna F; Narducci ML; Gabrielli F; Lanza GA; Bellocci F; Rebuzzi A; Crea F
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1363-7. PubMed ID: 25066621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis.
    Qian Z; Zhang Z; Guo J; Wang Y; Hou X; Feng G; Zou J
    Pacing Clin Electrophysiol; 2016 Jan; 39(1):81-8. PubMed ID: 26470761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.
    Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M
    Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients.
    Larsen GK; Evans J; Lambert WE; Chen Y; Raitt MH
    Heart Rhythm; 2011 Dec; 8(12):1881-6. PubMed ID: 21816127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.